| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 2,747,000 | 2,710,000 | 2,536,000 | 2,585,000 | | Cost of Revenue | 320,000 | 346,000 | 423,000 | 449,000 | | | Gross Profit | 2,427,000 | 2,364,000 | 2,113,000 | 2,136,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,158,000 | 1,032,000 | 987,000 | 979,000 | | Non Recurring | (1,000) | 12,000 | 4,000 | 5,000 | | Others | 839,000 | 701,000 | 551,000 | 389,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 431,000 | 619,000 | 571,000 | 763,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 431,000 | 619,000 | 571,000 | 763,000 | | Interest Expense | 182,000 | 187,000 | 241,000 | 256,000 | | Income Before Tax | 249,000 | 432,000 | 330,000 | 507,000 | | Income Tax Expense | 41,000 | 114,000 | 25,000 | 149,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 208,000 | 318,000 | 305,000 | 358,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 208,000 | 318,000 | 305,000 | 358,000 | | Preferred Stock And Other Adjustments | (87,000) | (47,000) | (21,000) |
-
| | | Net Income Applicable To Common Shares | $121,000 | $271,000 | $284,000 | $358,000 |
|
2.03% Nasdaq 0.00%
Income Statement
